Search results
Showing 3151 to 3165 of 9068 results
This indicator covers the percentage of patients with diabetes, on the register, with a diagnosis of nephropathy (clinical proteinuria) or micro-albuminuria who are currently treated with an ACE-I (or ARBs). It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM95.
Agenda and papers of the NICE public board meeting on 18 March 2026
GPs help to bring a primary care perspective to the guidance that we produce.
Read NICE's patient and public involvement policy.
People can comment on our guidance at specific stages in its development.
Home Get involved Help develop quality standards...
Home Get involved Help develop quality standards...
Home Get involved Help develop quality standards...
Involving you in the development of NICE guidance.
Home Get involved...
Help us improve NICE: take part in research to help us develop better products and services.
Training and development opportunities at NICE
Study NICE and LSE's Executive MSc Healthcare Decision-Making
Study NICE and LSE's Executive MSc Healthcare Decision-Making
International collaboration with NICE
Tell us what matters to you, your organisation or your community.